Senior Director, Corporate Affairs, Europe

Revolution Medicines · Basel, Switzerland · Engineering

Posted 2026-11-19

Apply for this role →

The Opportunity:

The Senior Director, Corporate Affairs, Europe will lead the development and execution of oncology-focused Corporate Affairs & Communications strategies in Europe that support the company’s mission of revolutionizing treatment for patients with RAS-addicted cancers. These strategies bring together media relations, corporate public affairs, product communications and corporate reputation management.

This is an intentionally broad remit, spanning a wide range of disciplines. We recognize that priorities will need to be set and will evolve over time. We are seeking a versatile leader who approaches this breadth as an opportunity and who understands that the scope of the role reflects the scale of our ambition as a growing business.

Reporting to the VP, Corporate Affairs, Europe, this role helps enable the success of local country organizations across the region. As part of a global team, this role also ensures that any activities in Europe align with global Corporate Affairs & Communications strategies.  The success of this role also relies on working in close collaboration with functions such as Medical Affairs, Commercial, Patient Advocacy, and Value, Pricing and Market Access.

Key Responsibilities:

Media Relations

Develops and executes proactive media content and strategies around trial results, regulatory milestones, and major oncology congresses (ASCO, ESMO).

Works closely with the Global Corporate Affairs to coordinate contact with top-tier European and trade media, ensuring accurate representation of company positions and activities.

Monitors media coverage and sentiment and develops effective response strategies.

Ensures consistent messaging across earned, owned, and shared channels, and aligns spokesperson strategy and media plans with global priorities.

Corporate Reputation Management and Corporate Public Affairs

Leads the company’s reputation strategy across Europe, supporting country teams and ensuring a consistent company message and identity. Ensures this is co-developed by countries and the Global Corporate Affairs.

Assesses how the company is viewed by key audiences and identifies risks to its reputation.

Leads the regional response to crises and sensitive issues, protecting the company’s reputation and maintaining trust.

Works with the Global Corporate Communications team to strengthen the profile and credibility of company leaders among business, healthcare, and policy audiences, establishing them as authoritative voices on advances in cancer treatment.

Partners with the regional Value, Market Access and Pricing team to engage government bodies and other key institutions on issues that affect the company’s ability to operate and grow across Europe.

Product and Disease Area Communications

Works with regional commercial teams to lead oncology communications across Europe, from disease awareness through product launch and throughout the product’s lifecycle. This includes activity at major congresses (ASCO, ESMO) that explains clinical data to healthcare professionals and media audiences, as permitted by local regulatory requirements.

Creates disease awareness content for patients and caregivers and partners with Medical Affairs to explain clinical data in communications for healthcare professionals.

Ensures communications comply with applicable European promotional codes, including EFPIA requirements, and local regulations, with a clear distinction between promotional and non-promotional communications and high ethical standards.

Capability Building (Technology and AI) and Regional Alignment

Builds the team’s ability to use AI tools to understand audiences, draft messages, and measure results, and sets clear standards for responsible, compliant use.

Develops practical resources, guidance, and training to strengthen country teams’ advocacy and policy skills, including their ability to use AI and digital tools.

Makes digital and AI tools an integral part of Corporate Affairs & Communications.

Partners with Global Corporate Affairs to ensure European communications are consistent with the company’s global messages.

Required Skills, Experience and Education:

Degree in Law, Communications, Political Science, Public Health, Life Sciences, or a related field.

Excellent leadership, influence, and team mindset.

Strong ability to develop and deliver impactful Corporate Affairs & Communications.

Excellent interpersonal, verbal, and written communication skills, including storytelling and policy translation for lay audiences.

Skilled in managing complex stakeholder environments and partnerships.

Minimum 10 years in Corporate Affairs & Communications in oncology.

Strong digital communications skills, with experience running campaigns and stakeholder engagement across web, social, and other digital channels.

Hands-on fluency with generative AI tools for communications workflows (drafting, monitoring, sentiment analysis), with an understanding of responsible use, disclosure, and governance in a regulated industry.

Deep understanding of the European healthcare policy and oncology landscape.

Proven track record of engaging with patient organizations, industry associations, and policymakers to deliver tangible policy and access outcomes.

Experience launching new oncology medicines and shaping policy to enable faster patient access.

Familiarity with reimbursement, HTA processes, and access barriers in oncology.

Preferred Skills:

Fluency in English, German, French, and/or Dutch is considered advantageous.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact careers@revmed.com.

#LI-LO1 #LI-Hybrid

Apply for this role →

← Back to all jobs